ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 30, 2025: -101.03%

ImmunityBio, Inc. Return on Assets (ROA) is -101.03% for the Trailing 12 Months (TTM) ending June 30, 2025, a -24.69% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 30, 2024 was -134.16%, a -10.93% change year over year.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 30, 2023 was -150.62%, a 39.15% change year over year.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 30, 2022 was -108.24%.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share